发明授权
EP1282604B1 SUBSTITUTED CAPROLACTAM CARBONATES AND ETHERS AND THEIR USE AS ANTI-TUMOR AGENTS
有权
取代碳酸己内酰胺和乙醚及其用途抗肿瘤活性
- 专利标题： SUBSTITUTED CAPROLACTAM CARBONATES AND ETHERS AND THEIR USE AS ANTI-TUMOR AGENTS
- 专利标题（中）： 取代碳酸己内酰胺和乙醚及其用途抗肿瘤活性
-
申请号： EP01975824.2申请日： 2001-05-09
-
公开(公告)号： EP1282604B1公开(公告)日： 2008-01-09
- 发明人: KINDER, Frederick, Ray, Jr. , VERSACE, Richard, William , BAIR, Kenneth, Walter
- 申请人： Novartis AG , Novartis Pharma GmbH
- 申请人地址： Lichtstrasse 35 4056 Basel CH
- 专利权人： Novartis AG,Novartis Pharma GmbH
- 当前专利权人： Novartis AG,Novartis Pharma GmbH
- 当前专利权人地址： Lichtstrasse 35 4056 Basel CH
- 代理机构： Gros, Florent
- 优先权： US568667 20000511
- 国际公布： WO2001085697 20011115
- 主分类号： C07D223/12
- IPC分类号： C07D223/12 ; A61K31/55 ; A61P35/00
摘要：
The present invention relates to certain substituted caporlactam carbonate and ether compounds of following formula (I): pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
公开/授权文献
信息查询
